ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

ClinicalTrials.gov ID: NCT02181257

Public ClinicalTrials.gov record NCT02181257. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts

Study identification

NCT ID
NCT02181257
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Washington University School of Medicine
Other
Enrollment
280 participants

Conditions and interventions

Interventions

  • Extracorporeal Photopheresis (ECP) Combination Product
  • No intervention in the SOC / Retrospective Chart review. Other

Combination Product · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2014
Primary completion
Mar 31, 2027
Completion
Nov 30, 2028
Last update posted
Apr 5, 2026

2015 – 2028

United States locations

U.S. sites
22
U.S. states
18
U.S. cities
21
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35226
St. Joseph's Hospital and Medical Center Phoenix Arizona 85013
University of California San Diego La Jolla California 92093
University of Florida Gainsville Florida 32610
Northwestern University Chicago Illinois 60611
Indiana University Health Indianapolis Indiana 46202
University of Iowa Iowa City Iowa 52242
University of Kentucky Lexington Kentucky 40506
Brigham and Women's Hospital Boston Massachusetts 02115
University of Michigan Health System Ann Arbor Michigan 48109
Spectrum Health Grand Rapids Michigan 45903
University of Minnesota Medical Center, Fairview Minneapolis Minnesota 55455
Washington University School of Medicine St Louis Missouri 63110
Columbia University New York New York 10032
Duke University Durham North Carolina 27710
Ohio State University Columbus Ohio 43210
Temple University Philadelphia Pennsylvania 19140
University of Pittsburgh Pittsburgh Pennsylvania 15213
Baylor University Medical Center Dallas Texas 75246
UT Southwestern Medical Center Dallas Texas 75390
Houston Methodist Houston Texas 77030
Inova Health System Falls Church Virginia 22042

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02181257, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02181257 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →